Nano-Based PSA Biosensors: An Early Detection Technique of Prostate Cancer

被引:3
|
作者
Najeeb, Mansoor Ani [1 ]
Pillai, Sankaranarayanan [2 ]
Chavali, Murthy [3 ]
机构
[1] Noorul Islam Ctr Higher Educ, Dept Biomed Engn, Kanyakumari 629180, Tamil Nadu, India
[2] Noorul Islam Ctr Higher Educ, Dept Chem, Kanyakumari 629180, Tamil Nadu, India
[3] VIGNAN Univ, Dept Sci & Human, Div Chem, Guntur 522213, Andhra Pradesh, India
关键词
Prostate Cancer; Biosensors; PSA; Sol-gel;
D O I
10.4028/www.scientific.net/JBBBE.20.87
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Prostate-specific antigen or PSA is a protein biomarker which is produced by the cells of prostate gland. The normal level of PSA in blood is often elevated in men with prostate cancer. In India, prostate cancer is one among the five, mostly cited cancer in men and it is getting increased by 1% every year. The screening test used for prostate cancer is the Prostate Specific Antigen test. The first PSA assay was determined in 1979. Most of the current techniques used for PSA detection are utilizing large analyzers, there by increased time and cost. Increased PSA levels can also because of prostatitis (inflammation of the prostate gland) or due to many other reasons. A proper technique to differential diagnose this disease is also an issue. The benchmark for the PSA level cannot be determined accurately. For this, various types of biosensors are used. This review journal is is trying to analyze variouus Nano-Biosensors used for early detection of PSA from blood in an early stage itself.
引用
收藏
页码:87 / 98
页数:12
相关论文
共 50 条
  • [21] Measurement of complexed PSA improves specificity for early detection of prostate cancer
    Brawer, MK
    Meyer, GE
    Letran, JL
    Bankson, DD
    Morris, DL
    Yeung, KK
    Allard, WJ
    [J]. UROLOGY, 1998, 52 (03) : 372 - 378
  • [22] Medical malpractice implications of PSA testing for early detection of prostate cancer
    Collins, MM
    Fowler, FJ
    Roberts, RG
    Oesterling, JE
    Annas, GJ
    Barry, MJ
    [J]. JOURNAL OF LAW MEDICINE & ETHICS, 1997, 25 (04): : 234 - +
  • [23] Malpractice implications of PSA testing for early detection of prostate cancer.
    Collins, MFM
    Barry, MJ
    Roberts, RG
    Fowler, FJ
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A406 - A406
  • [24] Debate Continues on Use of PSA Testing for Early Detection of Prostate Cancer
    Friedrich, M. J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2273 - 2276
  • [25] Complexed PSA for early detection of prostate cancer: A multi institutional study
    Vincent, RV
    Denis, CD
    Villers, AA
    Gibbod, LB
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 481 - 481
  • [26] Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer
    Tello, FL
    Prats, CH
    González, MDD
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (02) : 116 - 120
  • [27] Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer
    Lamy, Pierre-Jean
    Montels, Frederic
    Tosi, Diego
    Leizour, Benoit
    Bascoul-Mollevi, Caroline
    Castan, Florence
    Roques, Sylvie
    Nielloud, Fabien
    Rebillard, Xavier
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2013, 71 (05) : 537 - 544
  • [28] Nano-based delivery of RNAi in cancer therapy
    Xin, Yong
    Huang, Min
    Guo, Wen Wen
    Huang, Qian
    Zhang, Long zhen
    Jiang, Guan
    [J]. MOLECULAR CANCER, 2017, 16
  • [29] Nano-based targeting strategies for cancer treatment
    Chopra, Hitesh
    Kaur, Amanpreet
    Singh, Inderbir
    Sharma, Rahul Kumar
    Bin Emran, Talha
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2022, 105
  • [30] Nano-based delivery of RNAi in cancer therapy
    Yong Xin
    Min Huang
    Wen Wen Guo
    Qian Huang
    Long zhen Zhang
    Guan Jiang
    [J]. Molecular Cancer, 16